Director's Update

New Research From Effective Health Care Program—Child ADHD

• Collaboration with AHRQ & FDA to examine serious cardiovascular events in children taking medications for ADHD.
• Largest study to date—analyzed data from more than 1.2 million children and young adults from ages 2 to 24.
• Study found no evidence of increased risk of serious cardiovascular effects among children and young people who use ADHD medications.
• The possibility of a small risk cannot be ruled out because of the small number of cardiovascular events observed in the patients studied.

Cooper WO, et al. ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med 2011.

http://www.effectivehealthcare.ahrq.gov

Image: The first page of the cited article is shown.

Previous Slide         Contents         Next Slide